Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ana Lameirinhas"'
Autor:
Sandra Torres-Ruiz, Iris Garrido-Cano, Ana Lameirinhas, Octavio Burgués, Cristina Hernando, María Teresa Martínez, Federico Rojo, Begoña Bermejo, Marta Tapia, Juan Antonio Carbonell-Asins, Carlos Javier Peña, Ana Lluch, Juan Miguel Cejalvo, Eduardo Tormo, Pilar Eroles
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Despite progress in breast cancer treatment, a significant portion of patients still relapse because of drug resistance. The involvement of microRNAs in cancer progression and chemotherapy response is well established. Therefore, this study
Externí odkaz:
https://doaj.org/article/3a1b2fe95e2d47d181a620741b4f85f7
Autor:
Iris Garrido‐Cano, Anna Adam‐Artigues, Ana Lameirinhas, Juan F. Blandez, Vicente Candela‐Noguera, Federico Rojo, Sandra Zazo, Juan Madoz‐Gúrpide, Ana Lluch, Begoña Bermejo, Felix Sancenón, Juan Miguel Cejalvo, Ramón Martínez‐Máñez, Pilar Eroles
Publikováno v:
Cancer Communications, Vol 42, Iss 12, Pp 1412-1416 (2022)
Externí odkaz:
https://doaj.org/article/7c968fc3805d4bed95fdb0851caa2240
Autor:
Catarina Macedo-Silva, Vera Miranda-Gonçalves, Ana Lameirinhas, Joana Lencart, Alexandre Pereira, João Lobo, Rita Guimarães, Ana Teresa Martins, Rui Henrique, Isabel Bravo, Carmen Jerónimo
Publikováno v:
Cell Death and Disease, Vol 11, Iss 12, Pp 1-16 (2020)
Abstract Esophageal squamous cell carcinoma (ESCC), the most frequent esophageal cancer (EC) subtype, entails dismal prognosis. Hypoxia, a common feature of advanced ESCC, is involved in resistance to radiotherapy (RT). RT response in hypoxia might b
Externí odkaz:
https://doaj.org/article/06465f6b25844cd4bdf4c7005122d6c0
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Externí odkaz:
https://doaj.org/article/fbee937e52b54f87921dfdf5e773f5c0
Autor:
Vera Miranda-Gonçalves, Ana Lameirinhas, Catarina Macedo-Silva, João Lobo, Paula C. Dias, Verónica Ferreira, Rui Henrique, Carmen Jerónimo
Publikováno v:
Cells, Vol 9, Iss 4, p 1053 (2020)
Background: Renal cell carcinoma (RCC) displays a glycolytic phenotype (Warburg effect). Increased lactate production, impacting on tumor biology and microenvironment modulation, has been implicated in epigenetic mechanisms’ regulation, leading to
Externí odkaz:
https://doaj.org/article/0c81f089b75346fe9f1a1e5b0fc3296d
Publikováno v:
Frontiers in Genetics, Vol 9 (2018)
Alterations in the epigenome and metabolism affect molecular rewiring of cancer cells facilitating cancer development and progression. Modulation of histone and DNA modification enzymes occurs owing to metabolic reprogramming driven by oncogenes and
Externí odkaz:
https://doaj.org/article/3e040876df0d4c33b15c40544a591544
Autor:
Iris Garrido-Cano, Pilar Eroles, Birlipta Pattanayak, Raimundo Cervera, Ana Lameirinhas, Sandra Torres-Ruiz, Eduardo Tormo, Anna Adam-Artigues
Publikováno v:
Cancer and Metastasis Reviews. 41:77-105
Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain higher than desirable. Alterations in microRNAs have been linked to chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efc685c770470709d306586da48b175
https://doi.org/10.1007/s10555-021-09992-0
https://doi.org/10.1007/s10555-021-09992-0
Autor:
Birlipta Pattanayak, Ana Lameirinhas, Sandra Torres-Ruiz, Octavio Burgués, Ana Rovira, María Teresa Martínez, Marta Tapia, Sandra Zazo, Joan Albanell, Federico Rojo, Begoña Bermejo, Pilar Eroles
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13292
Treatment for the HER2+ breast cancer subtype is still unsatisfactory, despite breakthroughs in research. The discovery of various new molecular mechanisms of transcription factors may help to make treatment regimens more effective. The transcription
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db9be6c0a644149b69aa59aacd92c2f
Autor:
Rui Henrique, Begoña Bermejo, Soraya Simón, Belen Ortega, Pilar Eroles, Vera Constâncio, Carmen Jerónimo, Paula Lopes, Ana Lameirinhas, M. I. Martínez, Anna Adam-Artigues, Iris Garrido-Cano, Cristina Hernando, Ana Lluch, Juan Miguel Cejalvo
Publikováno v:
Cancer Research. 81:PS2-31
BACKGROUND: MicroRNAs have emerged as new diagnostic and therapeutic biomarkers for breast cancer. Herein, we analyzed miR-99a-5p expression levels in primary tumours and plasma of breast cancer patients to evaluate its usefulness as a minimally inva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6a2d082a072d398c8fdcba58a6715ff
https://doi.org/10.1158/1538-7445.sabcs20-ps2-31
https://doi.org/10.1158/1538-7445.sabcs20-ps2-31
Autor:
João Lobo, Catarina Macedo-Silva, Vera Miranda-Gonçalves, Ana Teresa Martins, Joana Lencart, Rui Henrique, Isabel Bravo, A. Pereira, Carmen Jerónimo, Ana Lameirinhas, Rita Guimarães
Publikováno v:
Cell Death and Disease, Vol 11, Iss 12, Pp 1-16 (2020)
Cell Death & Disease
Cell Death & Disease
Esophageal squamous cell carcinoma (ESCC), the most frequent esophageal cancer (EC) subtype, entails dismal prognosis. Hypoxia, a common feature of advanced ESCC, is involved in resistance to radiotherapy (RT). RT response in hypoxia might be modulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2e5e7c353439b2e4a5be71c0ac0c71
https://doaj.org/article/06465f6b25844cd4bdf4c7005122d6c0
https://doaj.org/article/06465f6b25844cd4bdf4c7005122d6c0